在年龄≥45 岁的人群中，mt-sRNA 检测对结直肠癌的敏感性为 94%，对高级腺瘤的敏感性为 46%。

In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.

机构信息

Vanderbilt University Medical Center, Nashville, Tennessee, USA (H.J.M.).

出版信息

Ann Intern Med. 2024 Feb;177(2):JC23. doi: 10.7326/J23-0114. Epub 2024 Feb 6.

DOI:10.7326/J23-0114

PMID:38316002

Abstract

Barnell EK, Wurtzler EM, La Rocca J, et al. JAMA. 2023;330:1760-1768. 37870871.

摘要

巴内尔 EK，沃特泽尔 EM，拉罗卡 J，等。JAMA。2023;330:1760-1768. 37870871.

相似文献

In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.

Ann Intern Med. 2024 Feb;177(2):JC23. doi: 10.7326/J23-0114. Epub 2024 Feb 6.

Multitarget Stool RNA Test for Colorectal Cancer Screening.

JAMA. 2023 Nov 14;330(18):1760-1768. doi: 10.1001/jama.2023.22231.

Performance of multitarget stool DNA testing in African American patients.

Cancer. 2018 Oct 1;124(19):3876-3880. doi: 10.1002/cncr.31660. Epub 2018 Sep 7.

Retrospective Review of Multitarget Stool DNA as a Screening Test for Colorectal Cancer.

Am Surg. 2023 Apr;89(4):603-606. doi: 10.1177/00031348211031844. Epub 2021 Jul 18.

Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.

Am J Gastroenterol. 2019 Dec;114(12):1909-1918. doi: 10.14309/ajg.0000000000000445.

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.

Cancer Prev Res (Phila). 2021 Sep;14(9):845-850. doi: 10.1158/1940-6207.CAPR-21-0075. Epub 2021 May 21.

Diagnostic accuracy of multitarget stool DNA testing for colorectal cancer screening: A systematic review and meta-analysis.

Gastroenterol Hepatol. 2022 Dec;45(10):753-766. doi: 10.1016/j.gastrohep.2022.01.007. Epub 2022 Jan 31.

Low Referral Rates for Genetic Assessment of Patients With Multiple Adenomas in United Kingdom Bowel Cancer Screening Programs.

Dis Colon Rectum. 2021 Sep 1;64(9):1058-1063. doi: 10.1097/DCR.0000000000001972.

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.

BMC Cancer. 2022 Dec 12;22(1):1299. doi: 10.1186/s12885-022-10372-2.

Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.

Mayo Clin Proc. 2021 May;96(5):1203-1217. doi: 10.1016/j.mayocp.2020.07.035. Epub 2021 Apr 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

在年龄≥45 岁的人群中，mt-sRNA 检测对结直肠癌的敏感性为 94%，对高级腺瘤的敏感性为 46%。

In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

在年龄≥45 岁的人群中，mt-sRNA 检测对结直肠癌的敏感性为 94%，对高级腺瘤的敏感性为 46%。

In persons aged ≥45 y, the mt-sRNA test had 94% sensitivity for colorectal cancer and 46% for advanced adenomas.

机构信息

出版信息

相似文献